Targacept , Inc. (NASDAQ:TRGT)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system.

Recs

0
Player Avatar pavlos1971 (99.61) Submitted: 8/1/2012 11:46:00 PM : Outperform Start Price: $4.25 TRGT Score: +15.18

Bought in RL@4.2795

Report this Post 1 Reply
Member Avatar pavlos1971 (99.61) Submitted: 8/14/2012 5:25:21 PM
Recs: 0

Closed in RL.

Report this Post

Featured Broker Partners


Advertisement